Therapies on Newly Diagnosed Type 2 Diabetes Patients With High Glucose Toxicity Which Protect Islet β Cell

NCT03180281 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

135

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: DPP4
DRUG: Insulin
DRUG: SU

Sponsor

First Affiliated Hospital Xi'an Jiaotong University